The PMEA programme rewards responsible customer-centric
business practices that ensure treatments and advice provide patients with
meaningful outcomes.
The awards have been specifically designed to recognise and
commend excellence, best practice and innovation on a local and global scale,
with programmes demonstrating a meaningful change in outcomes for patients.
2016 also marks the start of a new category - PMEA Support
Agency of the Year. This category recognises excellent work from companies in
support sectors who have provided their pharmaceutical clients with outstanding
assistance across their businesses.
The four categories Lucid entered and have been shortlisted
in are:
PMEA Support Agency of the Year – Lucid Group
·
Innovation – Advance Outcomes® –
An Innovative Model of Medical Education to Achieve Improved, Measurable
Healthcare and Patient Outcomes
Excellence in Healthcare Collaboration and
Partnerships – The Ulcerative Colitis Endoscopic Index of Severity Online
Tool
·
Excellence in Physicians / Healthcare
Provider Support Programmes – PEER: Psoriasis
Expert Exchange FoRum: Changing
clinical behaviour on a global scale to improve standards of care in the
management of psoriatic arthritis.
Dennis O’Brien (Lucid Co-founder and CEO)
commented “We are delighted to have made the shortlist in all four categories
we entered, in particular we are very proud to be finalists in the new category
of PMEA Support Agency of the Year. We aim to improve patient outcomes in
everything we do, and it is fantastic to be recognised for the support we
provide.”![]()
![]()
